Novartis won a potentially short-lived victory in its fight across multiple courts to keep generic versions of its ...

BridgeBio CEO Neil Kumar joins CNBC's 'Power Lunch' to discuss the company's latest drug developments, how the drugs compares ...

A team of researchers led by the University of California San Diego and Stanford University has developed a noninvasive ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

Metoprolol, acebutolol, and propranolol are heart medications linked to weight gain. Other heart medications may cause weight gain, but some might cause weight loss or be weight neutral.

The Supreme Court said Friday it will review the constitutionality of the Affordable Care Act’s no-cost coverage mandates for ...

In a recent article in the journal Antioxidants, researchers in Germany investigated whether cardiovascular drugs such as alpha-blockers and beta-blockers can protect against the complications ...

Cytokinetics' hopes of resurrecting cardiac myosin activator omecamtiv mecarbil have suffered another setback, after the drug failed to show a benefit in a phase 3 heart failure study.

Congestive heart failure is a disease state distinguished by the regular presence of both renal and hepatic abnormalities in drug handling. One such abnormality involves flaws in the process of ...

A top doctor has revealed which common medications taken by millions could put you at risk of a heart attack. Dr Zain Hasan, an anesthetist in California, highlighted non-steroidal anti ...